First and/or last author

Backmann HA, Larsen M, Danielsen AS, Hofvind S (2020)
Time of day and mammographic reader performance in a population-based breast cancer screening programme
J Med Screen, 0969141320953206
DOI 10.1177/0969141320953206, PubMed 32862773

Berge LAM, Andreassen BK, Stenehjem JS, Heir T, Furu K, Juzeniene A, Roscher I, Larsen IK, Green AC, Veierød MB, Robsahm TE (2020)
Use of Antidepressants and Risk of Cutaneous Melanoma: A Prospective Registry-Based Case-Control Study
Clin Epidemiol, 12, 193-202
DOI 10.2147/CLEP.S241249, PubMed 32110111

Blindheim A, Fosså S, Babigumira R, Myklebust TÅ, Haug E, Arum CJ, Andreassen BK (2020)
T1 bladder cancer in Norway: treatment and survival
Scand J Urol, 54 (5), 370-375
DOI 10.1080/21681805.2020.1803401, PubMed 32783590

Botteri E, Borroni E, Sloan EK, Bagnardi V, Bosetti C, Peveri G, Santucci C, Specchia C, van den Brandt P, Gallus S, Lugo A (2020)
Smoking and Colorectal Cancer Risk, Overall and by Molecular Subtypes: A Meta-Analysis
Am J Gastroenterol (in press)
DOI 10.14309/ajg.0000000000000803, PubMed 32773458

Dianatinasab M, Rezaian M, HaghighatNezad E, Bagheri-Hosseinabadi Z, Amanat S, Rezaeian S, Masoudi A, Ghiasvand R (2020)
Dietary Patterns and Risk of Invasive Ductal and Lobular Breast Carcinomas: A Systematic Review and Meta-analysis
Clin Breast Cancer, 20 (4), e516-e528
DOI 10.1016/j.clbc.2020.03.007, PubMed 32362500

Enerly E, Berger S, Kjær SK, Sundström K, Campbell S, Tryggvadóttir L, Munk C, Hortlund M, Thomas Group. Electronic address: thomas_group@merck.com, Joshi A, Saah AJ, Nygård M (2020)
Use of real-world data for HPV vaccine trial follow-up in the Nordic region
Contemp Clin Trials, 92, 105996
DOI 10.1016/j.cct.2020.105996, PubMed 32247041

Fosså SD, Aas K, Müller C, Jerm MB, Tandstad T, Lilleby W, Kvåle R, Gulbrandsen J, Haug E, Myklebust TA (2020)
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol, 155, 33-41 (in press)
DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165

Frisch D, Becker D, Wojewodzic MW (2020)
Dissecting the Transcriptomic Basis of Phenotypic Evolution in an Aquatic Keystone Grazer
Mol Biol Evol, 37 (2), 475-487
DOI 10.1093/molbev/msz234, PubMed 31722403

Graue R, Lönnberg S, Skare GB, Saether SMM, Bjørge T (2020)
Atypical glandular lesions of the cervix and risk of cervical cancer
Acta Obstet Gynecol Scand, 99 (5), 582-590
DOI 10.1111/aogs.13790, PubMed 31853943

Hashim D, Engesæter B, Baadstrand Skare G, Castle PE, Bjørge T, Tropé A, Nygård M (2020)
Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening
Br J Cancer, 122 (11), 1715-1723
DOI 10.1038/s41416-020-0790-1, PubMed 32242098

Hektoen HH, Robsahm TE, Andreassen BK, Stenehjem JS, Axcrona K, Mondul A, Gislefoss RE (2020)
Lifestyle associated factors and risk of urinary bladder cancer: A prospective cohort study from Norway
Cancer Med, 9 (12), 4420-4432
DOI 10.1002/cam4.3060, PubMed 32319230

Hjerkind KV, Larsen IK, Aaserud S, Møller B, Ursin G (2020)
Cancer incidence in non-immigrants and immigrants in Norway
Acta Oncol, 59 (11), 1275-1283
DOI 10.1080/0284186X.2020.1817549, PubMed 32930622

Hofvind S (2020)
Screening med 3D-mammografi – treffer bedre, men koster mer
Tidsskr Nor Laegeforen, 140 (5)
DOI 10.4045/tidsskr.20.0046, PubMed 32238960

Hofvind S, Mangerud G, Ursin G (2020)
Misvisende og tendensiøst om informasjon i Mammografiprogrammet
Tidsskr Nor Laegeforen, 140 (6)
DOI 10.4045/tidsskr.20.0246, PubMed 32321230

Hofvind S, Sebuødegård S (2020)
S. Hofvind og medarbeidere svarer
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.20.0379, PubMed 32463197

Hofvind S, Sebuødegård S, Botteri E (2020)
Response to Zahl
J Natl Cancer Inst, 112 (11), 1175
DOI 10.1093/jnci/djaa130, PubMed 32986835

Hovda T, Tsuruda K, Hoff SR, Sahlberg KK, Hofvind S (2020)
Radiological review of prior screening mammograms of screen-detected breast cancer
Eur Radiol
DOI 10.1007/s00330-020-07130-y, PubMed 33001307

Johansson ALV, Stensheim H (2020)
Epidemiology of Pregnancy-Associated Breast Cancer
Adv Exp Med Biol, 1252, 75-79
DOI 10.1007/978-3-030-41596-9_9, PubMed 32816264

Knudsen MD, Hoff G, Tidemann-Andersen I, Bodin GE, Øvervold S, Berstad P (2020)
Public Awareness and Perceptions of Colorectal Cancer Prevention: a Cross-Sectional Survey
J Cancer Educ
DOI 10.1007/s13187-020-01721-5, PubMed 32112366

Kvaerner AS, Harnaes H, Alavi DH, Barebring L, Henriksen HB, Guren MG, Lauritzen PM, Eggesbo HB, Wiedswang G, Smeland S, Blomhoff R (2020)
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
Tidsskr. Nor. Laegeforen., 140 (8), 783-788

Kværner AS, Harnæs H, Alavi DH, Bärebring L, Henriksen HB, Guren MG, Lauritzen PM, Eggesbø HB, Wiedswang G, Smeland S, Blomhoff R (2020)
Should calculation of chemotherapy dosage for bowel cancer be based on body composition?
Tidsskr Nor Laegeforen, 140 (8)
DOI 10.4045/tidsskr.19.0769, PubMed 32463187

Lambert PC, Andersson TM, Rutherford MJ, Myklebust TÅ, Møller B (2020)
Reference-adjusted and standardized all-cause and crude probabilities as an alternative to net survival in population-based cancer studies
Int J Epidemiol (in press)
DOI 10.1093/ije/dyaa112, PubMed 32829393

Larsen IK, Myklebust TÅ, Babigumira R, Vinberg E, Møller B, Ursin G (2020)
Education, income and risk of cancer: results from a Norwegian registry-based study
Acta Oncol, 59 (11), 1300-1307
DOI 10.1080/0284186X.2020.1817548, PubMed 32924698

Larsen M, Lilleborge M, Vigeland E, Hofvind S (2020)
Self-reported symptoms among participants in a population-based screening program
Breast, 54, 56-61 (in press)
DOI 10.1016/j.breast.2020.08.015, PubMed 32927237

Larsen M, Moshina N, Sagstad S, Hofvind S (2020)
Factors associated with attendance and attendance patterns in a population-based mammographic screening program
J. Med. Screen., 0969141320932945

Lilleborge M, Falk RS, Hofvind S (2020)
Number of prior negative screening outcomes does not influence future risk of breast cancer
Eur J Epidemiol, 35 (6), 549-556
DOI 10.1007/s10654-020-00645-0, PubMed 32430839

Lund E (2020)
La tallene få tale
Tidsskr Nor Laegeforen, 140 (12)
DOI 10.4045/tidsskr.20.0490, PubMed 32900169

Michalek IM, Kinnunen TI, Kjaerheim K, Lynge E, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Pukkala E (2020)
Smoking-adjusted risk of kidney cancer by occupation: a population-based cohort study of Nordic men
Acta Oncol, 59 (5), 582-587
DOI 10.1080/0284186X.2020.1714722, PubMed 32009517

Moshina N, Aase HS, Danielsen AS, Haldorsen IS, Lee CI, Zackrisson S, Hofvind S (2020)
Comparing Screening Outcomes for Digital Breast Tomosynthesis and Digital Mammography by Automated Breast Density in a Randomized Controlled Trial: Results from the To-Be Trial
Radiology, 297 (3), 522-531
DOI 10.1148/radiol.2020201150, PubMed 32930649

Myklebust TÅ, Andersson T, Bardot A, Vernon S, Gavin A, Fitzpatrick D, Jerm MB, Rutherford M, Parkin DM, Sasieni P, Arnold M, Soerjomataram I, Bray F, Lambert PC, Møller B (2020)
Can different definitions of date of cancer incidence explain observed international variation in cancer survival? An ICBP SURVMARK-2 study
Cancer Epidemiol, 67, 101759
DOI 10.1016/j.canep.2020.101759, PubMed 32544801

Nilbert M, Thomsen LA, Winther Jensen J, Møller H, Borre M, Widenlou Nordmark A, Lambe M, Brändström H, Kørner H, Møller B, Ursin G (2020)
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care
Acta Oncol, 59 (11), 1343-1356
DOI 10.1080/0284186X.2020.1820573, PubMed 32981417

Nilssen Y, Brustugun OT, Eriksen MT, Haug ES, Naume B, Møller B (2020)
Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016
BMC Cancer, 20 (1), 488
DOI 10.1186/s12885-020-06979-y, PubMed 32473650

Nygård M, Hansen BT, Kjaer SK, Hortlund M, Tryggvadóttir L, Munk C, Lagheden C, Sigurdardottir LG, Campbell S, Liaw KL, Dillner J (2020)
Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
Hum Vaccin Immunother
DOI 10.1080/21645515.2020.1814097, PubMed 32990181

Orumaa M, Kjaer SK, Dehlendorff C, Munk C, Olsen AO, Hansen BT, Campbell S, Nygård M (2020)
The impact of HPV multi-cohort vaccination: Real-world evidence of faster control of HPV-related morbidity
Vaccine, 38 (6), 1345-1351
DOI 10.1016/j.vaccine.2019.12.016, PubMed 31917039

Pedersen IB, Bretthauer M, Kalager M, Løberg M, Hoff G, Matapour S, Hugin S, Frigstad SO, Seip B, Kleist BA, Løvdal L, Botteri E, Holme Ø (2020)
Incomplete endoscopic resection of colorectal polyps: a prospective quality assurance study
Endoscopy
DOI 10.1055/a-1243-0379, PubMed 32961579

Raju SC, Viljakainen H, Figueiredo RAO, Neuvonen PJ, Eriksson JG, Weiderpass E, Rounge TB (2020)
Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition
Microbiome, 8 (1), 121
DOI 10.1186/s40168-020-00893-y, PubMed 32825849

Rehm J, Shield KD, Weiderpass E (2020)
Alcohol consumption. A leading risk factor for cancer
Chem Biol Interact, 331, 109280
DOI 10.1016/j.cbi.2020.109280, PubMed 33010221

Reigstad MM, Storeng R, Furu K, Bakken IJ, Engeland A, Larsen IK (2020)
Validation of Assisted Reproductive Technology in the Medical Birth Registry of Norway Versus the Norwegian Prescription Database
Epidemiology, 31 (5), 681-686
DOI 10.1097/EDE.0000000000001228, PubMed 32639249

Robsahm TE, Stenehjem JS, Berge LAM, Veierød MB (2020)
Prevalence of Indoor Tanning Among Teenagers in Norway Before and After Enforcement of Ban for Ages Under 18 Years
Acta Derm Venereol, 100 (8), adv00127
DOI 10.2340/00015555-3482, PubMed 32285136

Schwartz GG, Tretli S, Klug MG, Robsahm TE (2020)
Women who develop ovarian cancer show an increase in serum calcium and a decrease in serum albumin. A longitudinal study in the Janus Serum Bank Cohort
Gynecol Oncol, 159 (1), 264-269
DOI 10.1016/j.ygyno.2020.07.006, PubMed 32723677

Sebuødegård S, Botteri E, Hofvind S (2020)
Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway
J Natl Cancer Inst, 112 (8), 839-846
DOI 10.1093/jnci/djz220, PubMed 31848605

Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2020)
Surgical treatment of breast cancer in Norway 2003-2018
Tidsskr Nor Laegeforen, 140 (15)
DOI 10.4045/tidsskr.20.0090, PubMed 33118768

Sondén ECB, Sebuødegård S, Korvald C, Lømo J, Schlichting E, Brandal SHB, Hofvind S (2020)
Kosmetiske brystimplantater og brystkreft
Tidsskr Nor Laegeforen, 140 (3)
DOI 10.4045/tidsskr.19.0266, PubMed 32105043

Soper BC, Nygård M, Abdulla G, Meng R, Nygård JF (2020)
A hidden Markov model for population-level cervical cancer screening data
Stat Med, 39 (25), 3569-3590
DOI 10.1002/sim.8681, PubMed 32854166

Stenehjem JS, Babigumira R, Hosgood HD, Veierød MB, Samuelsen SO, Bråtveit M, Kirkeleit J, Rothman N, Lan Q, Silverman DT, Friesen MC, Robsahm TE, Kjærheim K, Andreassen BK, Shala NK, Liu FC, Strand LÅ, Grimsrud TK (2020)
Cohort Profile: The Norwegian Offshore Petroleum Workers (NOPW) Cohort
Int J Epidemiol (in press)
DOI 10.1093/ije/dyaa107, PubMed 32879941

Støer NC, Botteri E, Thoresen GH, Karlstad Ø, Weiderpass E, Friis S, Pottegard A, Andreassen BK (2020)
Drug use and cancer risk: a drug-wide association study (DWAS) in Norway
Cancer Epidemiol Biomarkers Prev (in press)
DOI 10.1158/1055-9965.EPI-20-1028, PubMed 33144282

Şuteu O, Blaga ML, Nygård M, Leinonen MK, Nicula F, Păiş R, Coza D, Cadariu PA, Melnic A, Andreassen T, Hashim D, Weiderpass E (2020)
Prevalence of positive screening test results and agreement between cytology and human papillomavirus testing in primary cervical cancer screening in North-Western Romania
Eur J Cancer Prev, 29 (2), 141-148
DOI 10.1097/CEJ.0000000000000522, PubMed 31033568

Thorkildsen J, Taksdal I, Bjerkehagen B, Norum OJ, Myklebust TA, Zaikova O (2020)
Risk stratification for central conventional chondrosarcoma of bone: A novel system predicting risk of metastasis and death in the Cancer Registry of Norway cohort
J Surg Oncol, 121 (7), 1115-1125
DOI 10.1002/jso.25883, PubMed 32141094

Thøgersen H, Møller B, Åsli LM, Bhargava S, Kvåle R, Fjellbirkeland L, Robsahm TE, Aaserud S, Babigumira R, Larsen IK (2020)
Waiting times and treatment following cancer diagnosis: comparison between immigrants and the Norwegian host population
Acta Oncol, 59 (4), 376-383
DOI 10.1080/0284186X.2019.1711167, PubMed 31920119

Trewin CB, Hjerkind KV, Johansson ALV, Strand BH, Kiserud CE, Ursin G (2020)
Socioeconomic inequalities in stage-specific breast cancer incidence: a nationwide registry study of 1.1 million young women in Norway, 2000-2015
Acta Oncol, 59 (11), 1284-1290
DOI 10.1080/0284186X.2020.1753888, PubMed 32319848

Trewin CB, Johansson ALV, Hjerkind KV, Strand BH, Kiserud CE, Ursin G (2020)
Stage-specific survival has improved for young breast cancer patients since 2000: but not equally
Breast Cancer Res Treat, 182 (2), 477-489
DOI 10.1007/s10549-020-05698-z, PubMed 32495000

Tsuruda KM, Hovda T, Bhargava S, Veierød MB, Hofvind S (2020)
Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review
Eur Radiol (in press)
DOI 10.1007/s00330-020-07340-4, PubMed 33180162

Umu SU, Langseth H, Keller A, Meese E, Helland Å, Lyle R, Rounge TB (2020)
A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis
Mol Oncol, 14 (2), 235-247
DOI 10.1002/1878-0261.12620, PubMed 31851411

Viljakainen J, Raju SC, Viljakainen H, Figueiredo RAO, Roos E, Weiderpass E, Rounge TB (2020)
Meal Regularity Plays a Role in Shaping the Saliva Microbiota
Front Microbiol, 11, 757
DOI 10.3389/fmicb.2020.00757, PubMed 32390990​